Embrace Surrogacy is categorized under Temporary Medical Services in Tustin, CA and active since 2011.
Embrace Surrogacy was established in 2011, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Temporary Medical Services business, which does work in the B2B market, and is classified as a Temporary Medical Services, under code number 561320 by the NAICS.
If you are seeking more information, feel free to contact Silbana Martinez Uribe at the company’s single location by writing to 10874 Kimball Place, Tustin, California CA 92782 or by phoning (714) 943-7350. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Embrace Surrogacy |
| Contact Person: | Silbana Martinez Uribe |
| Address: | 10874 Kimball Place, Tustin, California 92782 |
| Phone Number: | (714) 943-7350 |
| Website Address: | embracesurrogacy.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Temporary Medical Services |
| SIC Code: | 7363 |
| NAICS Code: | 561320 |
| Share This Business: |
Embrace Surrogacy was started in 2011 to provide professional Temporary Medical Services under the SIC code 7363 and NAICS code 561320. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Silbana Martinez Uribe for inquiries that concern Embrace Surrogacy by calling the company number (714) 943-7350, as your correspondence is most welcome. Additionally, the physical location of the single location of Embrace Surrogacy can be found at the coordinates 33.758014,-117.765471 as well as the street address 10874 Kimball Place in Tustin, California 92782.
For its online presence, you may visit Embrace Surrogacy’s website at embracesurrogacy.com and engage with its social media outlets through on Twitter and on Facebook.